Increased incidence of bronchopulmonary fistulas complicating pediatric pneumonia

Pediatric Pulmonology

Volumn 46, Issue 7, 2011, Pages 717-721

  McKee, A J ^a   Ives, A ^a   Balfour Lynn, I M ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Bronchopleural fistula; Empyema; Pneumococcus

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFUROXIME; PNEUMOCOCCUS VACCINE;

ARTICLE; BRONCHOPLEURAL FISTULA; CHILD; HUMAN; INCIDENCE; LENGTH OF STAY; PLEURA EMPYEMA; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; STREPTOCOCCUS PNEUMONIAE; THORAX DRAINAGE;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BRONCHIAL FISTULA; CHILD; CHILD, PRESCHOOL; EMPYEMA, PLEURAL; ENGLAND; FEMALE; HUMANS; INCIDENCE; INFANT; LENGTH OF STAY; MALE; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; RETROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE;

EID: 79959831360     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21396     Document Type: Article

References (17)

1. Byington CL, Spencer LY, Johnson TA, Pavia AT, Allen D, Mason EO, Kaplan S, Carroll KC, Daly JA, Christenson JC, Samore MH. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis 2002;34:434-440. (Pubitemid 34112262)
2. Eastham KM, Freeman R, Kearns AM, Eltringham G, Clark J, Leeming J, Spencer DA. Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax 2004;59:522-525.
3. Balfour-Lynn IM, Abrahamson E, Cohen G, Hartley J, King S, Parikh D, Spencer D, Thomson AH, Urquhart D. BTS guidelines for the management of pleural infections in children. Thorax 2005;60:i1-i21. (Pubitemid 40222909)
4. Kerem E, Bar Ziv Y, Rudenski B, Katz S, Kleid D, Branski D. Bacteremic necrotizing pneumococcal pneumonia in children. Am J Respir Crit Care Med 1994;149:242-244. (Pubitemid 24066127)
5. Sawicki GS, Lu FL, Valim C, Cleveland RH, Colin AA. Necrotising pneumonia is an increasingly detected complication of pneumonia in children. Eur Respir J 2008;31:1285-1291.
6. Hacimustafaoglu M, Celebi S, Sarimehmet H, Gurpinar A, Ercan I. Necrotizing pneumonia in children. Acta Paediatr 2004;93:1172-1177. (Pubitemid 39099715)
7. Hsieh YC, Hsiao CH, Tsao PN, Wang JY, Hsueh PR, Chiang BL, Lee WS, Huang LM. Necrotizing pneumococcal pneumonia in children: the role of pulmonary gangrene. Pediatr Pulmonol 2006;41:623-629.
8. Bradnock TJ, Crabbe D. Pneumothorax. In: Parikh DH, Crabbe DCG, Auldist AW, Rothenberg SS, editors. Pediatric thoracic surgery. London: Springer-Verlag London Ltd; 2009. pp. 465-480.
9. Ramphul N, Eastham KM, Freeman R, Eltringham G, Kearns AM, Leeming JP, Hasan A, Hamilton LJ, Spencer DA. Cavitatory lung disease complicating empyema in children. Pediatr Pulmonol 2006;41:750-753. (Pubitemid 44157358)
10. Bender J, Ampofo K, Korgenski K, Daly J, Pavia AT, Mason EO, Byington CL. Pneumococcal necrotizing pneumonia in Utah: does serotype matter? Clin Infect Dis 2008;46:1346-1352.
11. MacLeod CM, Krauss MR. Control by factors distinct from the S transforming principle of the amount of capsular polysaccharide produced by type III pneumococci. J Exp Med 1953;97:767-771.
12. Weinberger DM, Harboe ZB, Sanders EA, Ndiritu M, Klugman KP, Rückinger S, Dagan R, Adegbola R, Cutts F, Johnson HL, O'Brien KL, Anthony Scott J, Lipsitch M. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis 2010;51:692-699.
13. Harboe ZB, Thomsen RW, Riis A, Valentiner-Branth P, Christensen JJ, Lambertsen L, Krogfelt KA, Konradsen HB, Benfield TL. Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med 2009;6:e1000081. DOI: 10.1371/journal.pmed.1000081.
14. Hausdorff WP, Feikin DR, Klugman KP. Epidemiologic differences among pneumococcal serotypes. Lancet Infect Dis 2005;5:83-93.
15. Health Protection Agency. Invasive Pneumococcal Disease (IPD) in England & Wales after 7-valent conjugate vaccine (PCV7); potential impact of 10 and 13-valent vaccines. Available at: www.hpa.org.uk/web/HPAwebFile/HPAweb-C/ 1245581527892 (accessed on 29/06/2010).
16. Byington CL, Hulten KG, Ampofo K, Sheng X, Pavia AT, Blaschke AJ, Pettigrew M, Korgenski K, Daly J, Mason EO. Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah. J Clin Microbiol 2010;48:520-525.
17. PATH. Accelerating the advancement of vaccines against pneumococcal disease. Available at: www.path.org/projects/pneumococcal-protein-vaccine- project-partners.php (accessed on 29/06/2010).